Loading
Lantheus Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Maeusli Heinz Christoph, was filed 09 Mar 2021.
Insider Decl.
739
Thresholds
n/a
Buy Volume
€116,777
8 ops. · all time
Sell Volume
€395M
357 ops. · all time
Who traded when
BuySaleMary Anne Heino12 sales
Robert J. Marshall Jr.5 sales
Paul Blanchfield4 sales
Daniel Niedzwiecki2 sales
Rajiv A. Patel2 sales
James H. Thrall1 sale
+1 other insider
Since the insiders bought
- +167.8%Entry US$19.39 · Close at T+365 US$51.93
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Lantheus Holdings, Inc. Hold (neutral), based on 8 analysts. Average price target: US$106.99.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,092 of 26,250 companies
63.1
score / 100
Value49
Quality77
FCF yld5.3%
Earn yld3.6%
EV/EBITDA17.8x
ROE22%
Gross mgn61%
Net mgn15%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$100.24
Analyst consensus
8 analystsHold
US$102.50Target US$106.99(+7%)US$115.00
Income statement
RevenueUS$1.5B
Gross profitUS$942M61% margin
EBITDAUS$403.6M26% margin
Net incomeUS$233.6M17.7% margin
Valuation
PER (trailing)24.3x
PER (forward)15.7x
P/Book5.0x
Beta-0.06
Balance sheet & cash
Market capUS$6.5B
Total debtUS$619.4M
Free Cash FlowUS$348.6M
Debt / Equity48%
Profitability & ownership
ROE22.2%
ROA8.4%
% insiders1.7%
% institutions115.8%
Last declaration on 19 August 2026
Declarations739 total
2,536 shares@ US$100.910.0039% mcap100.0% of flowCommon StockSEC:0002064832-26-000278:0
463 shares@ US$100.910.0007% mcap65.2% of flowCommon StockSEC:0002064832-26-000277:0
381 shares@ US$96.670.0005% mcap2.8% of flowCommon StockSEC:0002064832-26-000219:0
1,911 shares@ US$83.820.0022% mcap2.7% of flowCommon StockSEC:0002064832-26-000171:0
133 shares@ US$76.3112.4% of flowCommon StockSEC:0002064832-26-000122:1
595 shares@ US$76.3111.3% of flowCommon StockSEC:0002064832-26-000121:1
1,182 shares@ US$76.310.4% of flowCommon StockSEC:0002064832-26-000123:1
1,283 shares@ US$76.311.2% of flowCommon StockSEC:0002064832-26-000125:1
36,692 shares0Common StockSEC:0002064832-26-000125:0
6,158 shares0Common StockSEC:0002064832-26-000122:0
26,208 shares0Common StockSEC:0002064832-26-000121:0
20,966 shares0Common StockSEC:0002064832-26-000124:0
38,002 shares0Common StockSEC:0002064832-26-000123:0
3,336 shares@ US$76.3062.7% of flowCommon StockSEC:0002064832-26-000112:1
41,916 shares@ US$76.306.3% of flowCommon StockSEC:0002064832-26-000110:1
8,259 shares@ US$76.307.5% of flowCommon StockSEC:0002064832-26-000113:1
10,652 shares@ US$76.303.7% of flowCommon StockSEC:0002064832-26-000111:1
5,169 shares0Common StockSEC:0002064832-26-000113:0
8,491 shares0Common StockSEC:0002064832-26-000111:0
32,105 shares0Common StockSEC:0002064832-26-000110:0
2,782 shares0Common StockSEC:0002064832-26-000112:0
368 shares@ US$66.576.0% of flowCommon StockSEC:0002064832-25-000088:1
356 shares@ US$93.4831.5% of flowCommon StockSEC:0002064832-25-000088:0
14,285 shares0Common StockSEC:0002064832-25-000020:0
727 shares@ US$54.900.3% of flowCommon StockSEC:0001062993-25-015276:0
25 of 739 declarations
About Lantheus Holdings, Inc.
At Lantheus Holdings, Inc., sales weigh EUR 456.1 million across 375 trades, with a median of EUR 146,657, against 8 purchases worth only EUR 116,777. The largest sale is by Rajiv A. Patel: EUR 162,159,948 on August 20, 2025. Avista Capital Partners GP, LLC, a 10% Owner, sold EUR 22,822,158 on June 20, 2017 and EUR 21,038,539 on May 9, 2017.
The three largest purchases are by Heinz Christoph Maeusli, Director, in early 2021: EUR 16,511 on February 12, EUR 16,036 on February 19 and EUR 15,542 on March 5. Purchases make up 2% of open-market trades.
Read moreShow less
Mary Anne Heino, Executive Chair and CEO, is the top filer, with 110 filings, 75 of them sales, ahead of Robert J. Marshall Jr., CFO and Treasurer (50). The record holds 727 filings, published from January 4, 2016 to August 19, 2026, including 290 grants and 26 option exercises. Annual volume reaches 104 in 2017, against 28 in 2016. The last twelve months count 24 filings, with no purchase or sale. Insiders hold 1.7% of the capital, across 39 filers. The US healthcare and pharma company is listed on Nasdaq and worth USD 6.52 billion.
